PCSK9抑制的不断变化的治疗场景
Brett S Mansfield1, Yakubu Bene-Alhasan2, Christie M Ballantyne3
1Carbohydrate & Lipid Metabolism Research Unit, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Atherosclerosis
|February 13, 2026
概括
蛋白转化酶亚素/素9型 (PCSK9) 抑制剂降低了LDL胆固醇,降低了心血管疾病的风险. 已批准的疗法和新型治疗方法为管理高胆固醇血症提供了新的选择.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 低密度脂蛋白 (LDL) 胆固醇是一种主要可修改的风险因素.
- 蛋白转化酶亚素/素9型 (PCSK9) 调节了LDL受体的表达,影响了LDL胆固醇水平.
研究的目的:
- 审查已批准的PCSK9抑制剂的证据.
- 讨论正在开发中的新型PCSK9向疗法.
- 为了探索PCSK9抑制的扩大指示.
主要方法:
- 关于PCSK9抑制剂的科学文献的综述.
- 已批准疗法临床试验数据的摘要.
- 讨论新兴的治疗策略,包括基因编辑.
主要成果:
- 功能丧失的PCSK9变体证实了其作为治疗点的作用.
- PCSK9抑制剂 (单克隆抗体,siRNA,口服药物) 有效地降低了LDL-C.
- 基因验证支持PCSK9作为高胆固醇血症的标.
结论:
- 抑制PCSK9是管理高胆固醇血症的有效策略.
- 有一系列针对PCSK9的治疗方法可用并且正在开发中.
- 抑制PCSK9对更广泛的心血管疾病预防有希望.
相关概念视频
Feedback Inhibition
57.4K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Enzyme Inhibition
92.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.9K
Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Therapeutic Communication
8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K
Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K


